Form 4: Metagenomi CFO Sells Shares for Tax Obligations Following RSU Vesting

Metagenomi, Inc.'s Chief Financial Officer, Pamela Wapnick, reported the sale of 1,576 shares of common stock at $1.75 per share to cover tax withholding obligations from the vesting of restricted stock units.

Summary

• Pamela Wapnick, Chief Financial Officer of Metagenomi, Inc. (MGX), reported a transaction on June 6, 2025.
• The transaction involved the sale of 1,576 shares of Metagenomi common stock at a price of $1.75 per share.
• This sale was not a volitional trade but an automatic sale to satisfy tax withholding obligations upon the vesting of restricted stock units (RSUs) granted to Ms. Wapnick on April 1, 2024.
• Following this transaction, Ms. Wapnick directly beneficially owns 72,108 shares of Metagenomi common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction is a routine, non-volitional sale for tax purposes related to RSU vesting, which is a standard practice in executive compensation and does not reflect a change in management's confidence or company performance.

Positives

• The transaction indicates the vesting of restricted stock units (RSUs), which is a form of compensation for the Chief Financial Officer, reflecting the company's compensation structure.

Negatives

• The sale, while non-volitional, results in a reduction of the Chief Financial Officer's direct beneficial ownership in the company by 1,576 shares.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.

Industry Context

This SEC Form 4 filing is a routine disclosure of an insider transaction, specifically a non-volitional sale of shares to cover tax obligations related to RSU vesting. It does not provide information relevant to broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The sale represents a minor reduction in insider ownership, but its non-volitional nature means it does not signal a lack of confidence. The overall impact on shareholders is minimal.
• Employees: The vesting of RSUs and subsequent tax-related sale is a standard component of executive compensation, which may be viewed as a positive for employee retention and motivation.

Key Dates

Keywords

Metagenomi, MGX, Form 4, Insider Transaction, Stock Sale, Chief Financial Officer, Pamela Wapnick, Restricted Stock Units, RSU Vesting, Tax Withholding